These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11568510)

  • 1. Apolipoprotein B Arg3500Gln mutation prevalence in children with hypercholesterolemia: a French multicenter study.
    Viola S; Benlian P; Morali A; Dobbelaere D; Lacaille F; Rieu D; Ginies JL; Maurage C; Meyer M; Lachaux A; Larchet M; Lenearts C; Goulet O; Sarles J; Mouterde O; Girardet JP;
    J Pediatr Gastroenterol Nutr; 2001 Aug; 33(2):122-6. PubMed ID: 11568510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
    Tybjaerg-Hansen A; Steffensen R; Meinertz H; Schnohr P; Nordestgaard BG
    N Engl J Med; 1998 May; 338(22):1577-84. PubMed ID: 9603795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic expression in double heterozygotes for familial hypercholesterolemia and familial defective apolipoprotein B-100.
    Benlian P; de Gennes JL; Dairou F; Hermelin B; Ginon I; Villain E; Lagarde JP; Federspiel MC; Bertrand V; Bernard C; Bereziat G
    Hum Mutat; 1996; 7(4):340-5. PubMed ID: 8723684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R3531C mutation in the apolipoprotein B gene is not sufficient to cause hypercholesterolemia.
    Rabès JP; Varret M; Devillers M; Aegerter P; Villéger L; Krempf M; Junien C; Boileau C
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E76-82. PubMed ID: 11031227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
    Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
    Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
    Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of familial defective apolipoprotein B-100 in Switzerland.
    Miserez AR; Laager R; Chiodetti N; Keller U
    J Lipid Res; 1994 Apr; 35(4):574-83. PubMed ID: 8006512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease.
    Tybjaerg-Hansen A; Humphries SE
    Atherosclerosis; 1992 Oct; 96(2-3):91-107. PubMed ID: 1466657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.
    Tai ES; Koay ES; Chan E; Seng TJ; Loh LM; Sethi SK; Tan CE
    Clin Chem; 2001 Mar; 47(3):438-43. PubMed ID: 11238294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic expression and frequency of familial defective apolipoprotein B-100 in Belgian hypercholesterolemics.
    Kotze MJ; Peeters AV; Langenhoven E; Wauters JG; Van Gaal LF
    Atherosclerosis; 1994 Dec; 111(2):217-25. PubMed ID: 7718024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children.
    van der Graaf A; Avis HJ; Kusters DM; Vissers MN; Hutten BA; Defesche JC; Huijgen R; Fouchier SW; Wijburg FA; Kastelein JJ; Wiegman A
    Circulation; 2011 Mar; 123(11):1167-73. PubMed ID: 21382890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypercholesterolemia due to ligand-defective apolipoprotein B100: first case report in a Mexican family.
    Robles-Osorio L; Ordoñez ML; Aguilar-Salinas CA; Aurón-Gómez M; Tusié-Luna MT; Gómez-Pérez FJ; Rull-Rodrigo JA
    Arch Med Res; 2003; 34(1):70-5. PubMed ID: 12604379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich.
    Schuster H; Rauh G; Kormann B; Hepp T; Humphries S; Keller C; Wolfram G; Zöllner N
    Arteriosclerosis; 1990; 10(4):577-81. PubMed ID: 2164382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial defective apolipoprotein B-100: molecular basis, prevalence and clinical features.
    Friedl W
    Wien Klin Wochenschr; 1991; 103(20):621-5. PubMed ID: 1763509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial defective apolipoprotein B-100.
    Hansen PS
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia.
    Innerarity TL; Mahley RW; Weisgraber KH; Bersot TP; Krauss RM; Vega GL; Grundy SM; Friedl W; Davignon J; McCarthy BJ
    J Lipid Res; 1990 Aug; 31(8):1337-49. PubMed ID: 2280177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial defective apolipoprotein B-100: a cause of hypercholesterolemia and early coronary heart disease.
    Nassar BA
    CMAJ; 1993 Feb; 148(4):579-80. PubMed ID: 8431820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.